Latest News & Features
Big Pharma
The multinational claims Mylan Pharmaceuticals’ generic of its blockbuster weight loss drug infringes another new patent | Complaint similar but separate to previous lawsuit against Mylan and Sun Pharma. 11 March 2025
Americas
Appeals court affirms PTAB’s invalidation of three heart monitoring patents | Decision voids limited exclusion order that temporarily halted Apple watch imports into the US. 11 March 2025
Careers
The ex-Cadwell Clonts Reeder & Thomas trial attorney and litigator represents clients in all phases of litigation in both federal and state courts, bringing particular experience of disputes in the Eastern and Southern Districts of Texas. 11 March 2025
Americas
Return-to-office orders, redundancies, hiring freezes—do changes sweeping through the US agency ‘risk breaking the system’? Marisa Woutersen finds patent practitioners fearful of the future. 6 March 2025
Americas
Senior legal voices from the world’s biggest companies share perspective on International Women’s Day theme | Action is key as gender parity remains a distant goal–forecasted to take at least 134 years. 6 March 2025
Americas
New York biotech scores win as Fed Circ upholds preliminary injunction against Celltrion's biosimilar launch | Ruling follows intense scrutiny during Federal Circuit oral arguments | Decision follows similar rulings against Samsung Bioepis and Formycon. 6 March 2025
Big Pharma
Federal Circuit says only patents claiming the active ingredient of a drug are eligible for listing | Injunction against Teva temporarily paused in January pending the appeal court’s decision to review. 4 March 2025
Careers
Based in Silicon Valley and San Francisco, the duo bring experience in patent litigation across life sciences, biotechnology, and high technology, including a recent victory overturning a $96 million jury verdict in an organ transplant testing case. 4 March 2025
Americas
Global listing of world’s IP experts undergoes a ‘significant transformation’, shifting from a volume-based listing to a selective and research-driven platform. 4 March 2025
Europe
UK biotech firm accuses luxury skincare brand La Prairie of misappropriating proprietary research on caviar-derived ingredients | Lawsuit claims La Prairie lacked expertise to develop the tech before accessing confidential trade secrets. 4 March 2025